©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: cannabis use disorder
UC San Diego Researchers: Cannabis Use Disorder Triples Risk of Oral Cancer
SAN DIEGO, Calif. -- A recent study by researchers at the University of California San Diego School of Medicine has found that individuals with...
PleoPharma Inc. Receives Third Patent
PHOENIXVILLE, Pa. --
The U.S. Patent Office issued to PleoPharma, Inc. a new patent focusing on the treatment of sleep disturbances, including sleep quality and...
FDA Fast-Tracks PleoPharma’s Investigational New Drug for Mitigation Cannabis Use Disorder Withdrawal
PHOENIXVILLE, Pa. -- The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PP-01, PleoPharma Inc.'s investigational new drug (IND) application for...
PleoPharma Receives Two U.S. Patents
PHOENIXVILLE, Pa. -- PleoPharma Inc., a privately held company focused on Cannabis-related health issues, has been issued two U.S. patents with broad claims relating to...
Indivior Provides Update on Aelis Farma’s Clinical Phase 2B Study Results in Participants with...
SLOUGH, England, and RICHMOND, Va. -- Indivior PLC is today providing an update following Aelis Farma's announcement of the results from its clinical Phase 2B trial with...
PLEOPHARMA,INC. REPORTS POSITIVE PHASE 2b CLINICAL TRIAL DATA FOR MITIGATION OF CANNABIS WITHDRAWAL
PHOENIXVILLE, Pa. -- PleoPharma Inc., a privately held company focused on cannabis related health issues, announced Phase 2b study results for its lead drug candidate, PP-01,...